Tripartite Therapeutics Company Description

Tripartite Therapeutics Inc. engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan.

Its proprietary OmniLink technology, helps in the therapeutic potential of active pharmaceutical ingredients that were previously limited by toxicities, in vivo stabilities, and unfavorable pharmacokinetic profiles.

The company aims to generate a pipeline of treatments for cancer tumors, unmet medical needs in oncology, metabolic diseases, vaccines, and other disease indications.

The company was founded in 2009 and is headquartered in Taipei, Taiwan.

Tripartite Therapeutics Inc.

Country	Taiwan
Founded	2009
Industry	Biological Products, Except Diagnostic Substances
CEO	Anthony Lin

Contact Details

Address: Ruihu Street Taipei, 114 Taiwan
Phone	886 2 2790 2895
Website	2t-pharma.com

Stock Details

Ticker Symbol	7920
Exchange	Taipei Exchange
Stock Type	Common Stock
Reporting Currency	TWD
SIC Code	2836

Key Executives

Name	Position
Anthony Lin	Chief Executive Officer
Yu-min Huang	Chief Financial Officer